HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early labor initiation with oral PGE2 after premature rupture of the membranes at term.

Abstract
Two groups of healthy women at term, who were not in labor 3 hours after premature rupture of the membranes, were studied. In one group labor induction with oral prostaglandin E2 (PGE2) was begun 3 hours after rupture, and in the other group intravenous oxytocin induction was begun 12 hours after rupture. PGE2 was successful in initiating active labor in 88% of women treated. Of the women who were observed for 12 hours, one-half began labor spontaneously during that time. Women in whom labor was induced with PGE2 given 3 hours after rupture of the membranes had a shorter interval of rupture to delivery, a lower cesarean section rate, and shorter postpartum hospitalization. Although significant bradycardia did not occur in fetuses of those women given PGE2, 10% of infants whose mothers were receiving oxytocin were delivered by cesarean section for this reason. It is concluded that oral PGE2 is safe and effective for induction of labor in women with premature membrane rupture. The benefits, to both mother and fetus, of a shorter latent period are discussed.
AuthorsJ C Hauth, F G Cunningham, P J Whalley
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 49 Issue 5 Pg. 523-6 (May 1977) ISSN: 0029-7844 [Print] United States
PMID850563 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Prostaglandins E
  • Oxytocin
Topics
  • Adult
  • Extraembryonic Membranes (physiology)
  • Female
  • Fetal Death
  • Fetal Heart (drug effects)
  • Fetal Membranes, Premature Rupture (physiopathology)
  • Heart Rate (drug effects)
  • Humans
  • Labor, Induced
  • Labor, Obstetric
  • Maternal Mortality
  • Monitoring, Physiologic
  • Oxytocin (therapeutic use)
  • Pregnancy
  • Prostaglandins E (administration & dosage, therapeutic use)
  • Puerperal Infection (etiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: